UK Clinical Research Network : Portfolio Database User Guide  
Welcome to the UK Clinical Research Network Study Portfolio  


NB: The information displayed below does not replace the protocol. The latest protocol version should always be consulted before making clinical decisions.
Pilot Brief Intervention on Inpatient Units

A Pilot Study to Assess the Feasibility and Impact of a Motivational Intervention on Problem Drug and Alcohol Use in Adult Mental Health Inpatient Units

Specialty
MentalHealth
Portfolio Eligibility
Automatically eligible
ISRCTN 43548483
EudraCT
MREC N° 12/WM/0369
UKCRN ID 13978
WHO ID
Research Summary
Background: Substance misuse in those with severe mental health problems is common and associated with poor engagement in treatment and treatment outcomes. Up to 44% of those admitted into psychiatric inpatient facilities have co-existing substance misuse problems. However, this is not routinely addressed as part of their treatment plan. A mental health admission can present an unparalleled window of opportunity for inpatients to re-evaluate the impact of their substance use. This study will aim to evaluate the effectiveness of a targetted brief motivational intervention in improving engagement in treatment; and assess how feasible and acceptable this intervention is to inpatients and staff as a routine intervention. Methods/Design: This randomised controlled trial will use concealed randomisation; blind, independent assessment of outcome at 3-months; characterisation of refusers and drop-outs; and be analysed according to the intention to treat principle. Following baseline assessments eligible participants will be randomised to either the Brief Integrated Motivational Intervention in the context of Treatment As Usual or Treatment as usual alone. Eligible participants will be those who are: new admissions; >18 years; ICD-10 diagnosis of -schizophrenia or related disorder, bipolar affective disorder, recurrent depressive disorder and DSM-IV diagnosis of substance abuse or dependence over the last three months. The primary outcome is engagement in treatment for substance misuse and secondary outcomes include readiness to change substance misuse together with a cost effectiveness analysis. Qualitative interviews with staff and participants will assess the acceptability of the intervention.
Study Type Interventional
Design Type Treatment
Disease(s) Addictions
Addictive Substances– alcohol
Addictive Substances– illegal drugs
Schizophrenia
Phase Pilot/Feasibility
Current Status Open
Closure Date 9/30/2014
Global Sample Size 68
Global Recruitment to Date
86%
Geographical Scope Single Centre
Lead Country England
Open to new sites No
Main Inclusion Criteria
• Adult (aged 18-65 years)
• Service users of BSMHFT Community mental health services
• Admitted to BSMHFT mental health inpatient units
• Assessed by the Responsible Clinical Officer as having capacity to consent
• Have a Care Co-ordinator in BSMHFT Community Mental Health Teams
• With severe mental health problems with one of the following diagnoses:
• ICD-10 schizophrenia, schizoaffective or delusional disorders (F20,22,23,25,28,29); Bipolar affective disorders (F31);
Recurrent depressive disorder without psychotic symptoms (F33.2) (32).
• Misusing alcohol and/or drugs (abuse/dependent use based on DSM-IV diagnostic criteria for substance-related disorders) over the last six months,based on a minimum score of 3 on the Clinicians Alcohol/Drugs Use rating scale (33).
If participants are readmitted to the in-patient units they will be reallocated to the treatment they were assigned previously.
Main Exclusion Criteria
Do not meet the inclusion criteria
Are unable to provide informed consent
Do not speak English sufficiently for them to be able to complete the questionnaires and engage in the motivational intervention.
Chief Investigator(s)
Dr Hermine Graham
Further details, please contact
Miss Latoya Clarke

University of Birmingham
School of Psychology
Edgbaston
Birmingham
West Midlands
B15 2TT
UNITED KINGDOM

l.clarke@bham.ac.uk
Dr Hermine Graham

University of Birmingham
School of Psychology
Edgbaston
Birmingham
West Midlands
B15 2TT
UNITED KINGDOM

Tel: 0121 414 7204
h.l.graham.1@bham.ac.uk
Ms Chrysi Stefanidou

University of Birmingham
School of Psychology
Edgbaston
Birmingham
West Midlands
B15 2TT
UNITED KINGDOM

Tel: 0121 414 7208
c.stefanidou@bham.ac.uk
Ms Kathryn Walsh

University of Birmingham
School of Psychology
Edgbaston
Birmingham
West Midlands
B15 2TT
UNITED KINGDOM

Tel: 0121 414 7208
k.walsh@bham.ac.uk
Funder(s) NIHR Research for Patient Benefit (RfPB)
Sponsor(s) Birmingham and Solihull Mental Health NHS Foundation Trust




public.ukcrn.org.uk/search
If you experience problems using the application, please click here.